Group B streptococcus colonization in pregnant diabetic women. 1997

E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, USA.

OBJECTIVE To evaluate the influence of maternal diabetes on the risk of group B streptococcus colonization during pregnancy. METHODS We prospectively analyzed data on 105 pregnant women with diabetes mellitus, both pregestational and gestational, and a control group of 300 pregnant women without carbohydrate intolerance. All had singleton gestations, negative tests for human immunodeficiency virus, and intact membranes at enrollment. Culture specimens for group B streptococcus were obtained from the lower vaginal walls and rectum. Two-tailed unpaired Student t test, Mann-Whitney U test, and chi 2 test were used as appropriate. Multiple logistic regression analyses were performed to evaluate the independent influence of maternal diabetes on the rate of group B streptococcus colonization. RESULTS Compared to controls, diabetic women had a higher colonization rate (43.8 versus 22.7%, odds ratio [OR] 2.56, 95% confidence interval [CI] 1.6, 4.1). The prevalence of group B streptococcus colonization in pregestational diabetic women was 54.1% and in women with gestational diabetes it was 35.1% (P = .05). Among women with pregestational diabetes, the prevalence of group B streptococcus colonization was 59.1% in class B and 50.0% in class C to R (P = not significant). After we adjusted for maternal age, race, and obesity, diabetic women continued to be at increased risk of group B streptococcus colonization (OR 3.1, 95% CI 1.8, 5.2). CONCLUSIONS Carbohydrate intolerance appears to be an independent risk factor for group B streptococcus colonization during pregnancy.

UI MeSH Term Description Entries
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011254 Pregnancy in Diabetics The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy. Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection

Related Publications

E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
March 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
January 1981, The Journal of infectious diseases,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
June 2019, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
March 2006, Ginecologia y obstetricia de Mexico,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
February 1977, The Journal of infectious diseases,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
January 2011, Epidemiology and health,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
May 2021, BMC infectious diseases,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
September 2020, Ethiopian journal of health sciences,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
May 2019, BMC pregnancy and childbirth,
E Ramos, and F L Gaudier, and L R Hearing, and G O Del Valle, and S Jenkins, and D Briones
March 2020, Infection & chemotherapy,
Copied contents to your clipboard!